公司资料
Vir Biotechnology 股价、新闻与催化剂
- 股票代码:
- VIR
- 交易所:
- NASDAQ
- 行业:
- Biopharma
- 所在地:
- United States
股票表现
9.91 USD (+1.33%)
收盘价
最后更新: 2026年8月24日
1.47B USD
市值
股价为何变动
As of Aug 24, 2026, VIR closed up 1.33% at $9.91. No new same-company headline was identified in the current news window.
公司概览
业务概览
Vir Biotechnology is an immunology and infectious-disease company built around antibody science and platform partnerships.
所在地与行业分类
Headquartered in the United States and listed on NASDAQ, Vir sits in specialty biotechnology.
商业模式特征
Its model depends on clinical development, collaboration revenue, and finding durable programs beyond the pandemic era.
生物医药行业定位
Vir remains a platform-heavy biotech name, but investors need the pipeline to deliver clear differentiation to keep the story moving.
未来催化剂
- Vir Biotechnology's catalysts are tobevibart plus elebsiran in hepatitis D, along with the rest of the hepatitis B franchise. The stock will care about whether the antiviral platform can keep finding a clear regulatory and commercial path.
近期新闻
相似股票
商业成熟度、治疗领域或催化剂模式相近的同行公司。